Immunomodulatory activity of a potent thymopentin analog: Disulphide bridged β-mercaptopropionyl-arginyl-lysyl-aspartyl-valyl-tyrosyl-cysteine amide

Polish Journal of Pharmacology

Volumn 48, Issue 1, 1996, Pages 31-38

  Wieczorek, Zbigniew ^a   Zimecki, Michał ^a   Trojnar, Jerzy ^b   Siemion, Ignacy Z ^c  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b Ferring AB   (Sweden)

^c UNIVERSITY OF WROC AW   (Poland)

Author keywords

disulphide bridged; mechanism of biological action; peptide immunomodulators; thymopentin analogs

Indexed keywords

BETA MERCAPTOPROPIONYLARGINYLLYSYLASPARTYLVALYLPROPYLCYSTEINAMIDE; BETA MERCAPTOPROPIONYLARGINYLLYSYLASPARTYLVALYLTYROSYLCYSTEINAMIDE; BETA MERCAPTOPROPIONYLARGINYLLYSYLDEXTROPROPYLVALYLTYROSYLCYSTEINAMIDE; IMMUNOMODULATING AGENT; THYMOPENTIN; THYMOPENTIN DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG POTENCY; DRUG SYNTHESIS; ERYTHROCYTE AGGREGATION; IMMUNOMODULATION; NONHUMAN; ROSETTE FORMATION; SHEEP; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AZATHIOPRINE; CELLS, CULTURED; ERYTHROCYTES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LEUKEMIA P388; LYMPHOCYTES; MICE; MICE, INBRED CBA; RECOMBINANT PROTEINS; ROSETTE FORMATION; SPLEEN; T-LYMPHOCYTES; THYMOPENTIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029889746     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Blake J., Helmeste D. M., Li C. H.: β-Endorphin. Synthesis and biological activity of analogs with disulfide bridge. Int. J. Peptide Prot. Res., 1985, 25, 575-579.
2. Conlon P. J.: A rapid biologic assay for the detection of interleukin 1. J. Immunol., 1983, 131, 1280-1281.
3. Dardenne M., Bach J. E: The sheep cell rosette assay for the evaluation of thymic hormons. In: The Biological Activity of Thymic Hormones. Ed. van Bekkum D. W. Kooyker Scientific Publications, Rotterdam, 1975, 235.
4. Darman P. S., Landis C. C., Smith J. R., Hirning L. D., Gulya K., Yamamura H. I., Burkes T. F. Hruby J. V.: Conformationally restricted cyclic analogs of Substance P; insight into the receptor binding process. Biochem. Biophys. Res. Commun., 1985, 127, 656-662.
5. Espevik T., Nissen-Meyer J.: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Meth., 1986, 95, 99-105.
6. Giełdanowski J., Błaszczyk B., Raberger G., Duś D.: Investigations of pharmacological and immunological properties of imuthiol. Arch. Immunol. Ther. Exp., 1990, 38, 249-257.
7. 13C-NMR procedure. Polish J. Chem., 1992, 66, 1269-1275.
8. Hansen M. B., Nielsen S. E., Berg K.: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth., 1989, 119, 203-210.
9. Mishell R. I., Dutton R. W.: Immunization of dissociated spleen cells cultures from normal mice. J. Exp. Med., 1967, 236, 423-442.
10. Mosberg H. I., Schiller P. W.: H NMR investigation of conformation features of cyclic encephalinamide analogs. Int. J. Peptide Prot. Res., 1984, 23, 462-466.
11. Mossman T.: Rapid colorimetric assay for cellular growth and cytotoxicity assays. J. Immunol. Meth., 1983, 119, 65, 55.
12. (22-26). Liebigs Ann., 1990, 245-247.
13. Pȩdyczak A., Trojnar J., Siemion I. Z.: The conformational studies on the heterodetic cyclic analogues of thymopentin. Polish J. Chem., 1994, 68, 2181-2199.
14. Fȩdyczak A., Wieczorek Z., Trojnar J., Bolewska-Pȩdyczak E., Lawitz K., Siemion I. Z.: Conformational and biological studies on proline containing thymopentin analogues. Polish J. Chem., 1994, 68, 1003-1008.
15. Pelton J. T., Gulya K., Hruby V. J., Duckies S P., Yamamura H. L: Conformationally restricted analogs of somatostatin with high M-opiate specificity. Proc. Nat. Acad. Sci. USA, 1985, 82, 236-239.
16. Sundal E.: Thymopentin and infection prophylaxis in cancer patients: a review. Int. J. Immunother., 1992, 8, 101-113.
17. Sundal E., Bertelletti D.: Thymopentin treatment of rheumatoid arthritis. Arzneim.-Forsch. Drug Res., 1994, 44(II), 1145-1149.
18. 32-36 pentapeptide in human plasma. Int. J. Peptide Prot. Res., 1979, 14, 479-484.
19. Van Ginckel R. E, Hoebeke J.: Effects of Levamisole on spontaneous rosette-forming celts in murine spleen. Eur. J. Immunol., 1976, 6, 305-307.
20. 2-terminal amino acid sequence of a T-cell-derived Iymphokine with growth factor activity for B-cell hybridomas. Proc. Nat. Acad. Sci. USA, 1986, 83, 9679-9683.
21. 5-TP5. Mol. Immunol., 1991, 28, 95-98.
22. Zimecki M., Wieczorek Z.: Interleukin-1 decreases the level of thymocytes forming rosettes with autologous erythrocytes: a new method of determination of Interleukin-1 activity. Arch. Immunol. Ther. Exp., 1987, 35, 371-379.